Clinical Trial Update: Clinical Study of Selinexor-Based Chemotherapy With Minimal or No Cytotoxic Agents in Treatment-Naïve AML Patients Unsuitable for Intensive Therapy: Focusing on Rapid Reduction of Blast Cells [NA]

View source ↗

Summary

A clinical study is planned to evaluate selinexor-based chemotherapy with minimal or no cytotoxic agents in treatment-naïve acute myeloid leukemia patients who …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Selinexor (selinexor)

Snippet

Sponsor: Donghua Zhang | Conditions: AML (Acute Myeloid Leukemia) | NA | Status: NOT_YET_RECRUITING